Fundraising Fox
Guardian Bio
YC S22Boston, US · Founded 2022 · 2 employees · 4 known investors
Find your way into Guardian Bio
Sign up to see every warm intro you have to Guardian Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Guardian Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Guardian Bio develops dendritic cell therapy for solid tumors by generating cDC1 cells from patient stem cells to restore immune function in cancer treatment. The company targets late-stage cancer patients who have dysfunctional antigen presentation.
Also known as GuardianBio
BiotechHealthtechMedical DevicesHealthcareTherapeuticsOncologyUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S22)
Guardian Bio was founded in 2022 by Ananya Zutshi, Ricky Barrett, and Dr. Palucka.
AZ
Ananya ZutshiCo-FounderShe holds a Bachelor of Science in Engineering from Duke University and a Master's degree in Engineering plus an MBA from Harvard University, with professional experience in pharmaceutical and biotech operations, engineering, project management, and early-stage investing.
RB
Ricky BarrettCo-Founder and CSO / COO2022–2025He began his career as a marine biologist and research diver at Florida Atlantic University studying marine natural products and drug discovery, then earned a PhD in immunology from UCF and completed a postdoctoral fellowship in cancer immunology and tumor microenvironment at the University of Pennsylvania.
DP
Dr. PaluckaAcademic Co-Founder, Chair, Scientific Advisory Board
Investors · 4
Y Combinatorlisted by Y CombinatorSan Francisco · $500K
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Brazen CapitalreportedTorrance
How we know: Y Combinator's founder network · Not right? Tell us
Fundament Syndicatereported
How we know: Y Combinator's founder network · Not right? Tell us
Phoenix FundreportedNew York
How we know: Y Combinator's founder network · Not right? Tell us
Related companies · 9
Velorum TherapeuticsVelorium develops transformational medicines by combining scientific research with patient-focused collaboration. The company operates in the medical research and therapeutic development space.
Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
Adventris PharmaceuticalsAdventris is a biotechnology company developing cancer immunotherapy treatments.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
SynsoryBioSynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
Guardant HealthGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
Eris BiotechEris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
iOrganBioiOrganBio builds CellForge, an AI- and automation-driven platform for engineering and manufacturing human cells and organoids.
Orca BioOrca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.
Companies working in the same space as Guardian Bio.
Legal entities · 1
corporate structureGuardian Bio Inc.
In the news
Frequently asked questions
- What does Guardian Bio do?
- Guardian Bio develops dendritic cell therapy for solid tumors by generating cDC1 cells from patient stem cells to restore immune function in cancer treatment. The company targets late-stage cancer patients who have dysfunctional antigen presentation.
- Who founded Guardian Bio?
- Guardian Bio was founded by Ananya Zutshi, Ricky Barrett, Dr. Palucka in 2022.
- Who are Guardian Bio's investors?
- Guardian Bio's investors include Y Combinator, Brazen Capital, Fundament Syndicate, Phoenix Fund.
- Where is Guardian Bio headquartered?
- Guardian Bio is headquartered in Boston, US.